Karyopharm Therapeutics Announces The Appointment Of Chief Accounting Officer
(MENAFN- PR Newswire) NEWTON, Mass., Nov. 20, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI ), a commercial-stage Pharmaceutical company pioneering novel cancer therapies, today announced that Kristin Abate, the Company's Vice …